Jeffrey Bacha

Co-Founder of DelMar Pharmaceuticals, Inc. $DMPI

[Jeffrey Bacha @JeffreyBacha]

It was an honor to present an update on @DelMarPharma's ongoing clinical trials of VAL-083 at #AACR18 with my Co-Founder and Chief Scientific Officer Dr. Dennis Brown. $DMPI

[Jeffrey Bacha @JeffreyBacha]

.@rosadelauro It was a pleasure meeting you. Thank you for taking the time to speak with the DelMar team & for all of your work with the bipartisan Congressional #OvarianCancer Caucus

[Jeffrey Bacha @JeffreyBacha]

Thank you @OCRFA for speaking with DelMar during our visit to Washington D.C. Learn about their work in the fight against #OvarianCancer https://t.co/UOomXxO4IY

[Jeffrey Bacha @JeffreyBacha]

Thank you to @RepAnnaEshoo & her staff for taking the time to speak with the DelMar team & for your dedication in the fight against #cancer

[Jeffrey Bacha @JeffreyBacha]

Thank you to @theNCI researchers for meeting with the DelMar team today ahead of the @NBTSTweets Research Roundtable.

[American Brain Tumor Association @theABTA]

.@JeffreyBacha, co-founder & CEO of @DelMarPharma, will discuss DelMar innovations at #BT5KTwinCities. Join us tmrw! https://t.co/T6hvM9MYa0

[Jeffrey Bacha @JeffreyBacha]

Thank you @wallstanalyzer for having me to discuss $DMPI's four clinical trials of our lead product VAL-083 https://t.co/ld829NWQXa

[Jeffrey Bacha @JeffreyBacha]

Thank you @upticknewswire for having me to discuss DelMar & our development programs of our lead product VAL-083 https://t.co/VunvNmdmj4

[Jeffrey Bacha @JeffreyBacha]

Addressing MGMT-unmethylated GBM represents one of the largest unmet needs in the treatment of #cancer today https://t.co/jWjzHyRXxf

[Jeffrey Bacha @JeffreyBacha]

Goal of our Ph 2 study to establish VAL-083 + radiation as alternative to TMZ + radiation for MGMT-unmethylated GBM https://t.co/jWjzHyRXxf

[Jeffrey Bacha @JeffreyBacha]

Our new Ph 2 trial leverages historical data demonstrating promising activity of VAL-083 in newly diagnosed #GBM https://t.co/jWjzHyRXxf

[Jeffrey Bacha @JeffreyBacha]

Listen to my Rodman & Renshaw presentation today at 12:05PM ET where I'll discuss our pivotal STAR-3 trial https://t.co/wzT0RYARRd $DMPI

[DelMar Pharma @DelMarPharma]

DelMar CEO Jeffrey Bacha and GBM patient Rob Thomson at the Finish Line of The British Columbia Ride to Conquer Cancer.

[Jeffrey Bacha @JeffreyBacha]

It was an honor riding with @BrainiacsCT in @TheBCRide, thank you to everyone for your donations & support!

[Jeffrey Bacha @JeffreyBacha]

Valuable lessons can be learned from first-hand experiences, concerns, thoughts & feelings expressed by GBM patients https://t.co/fOG47qvOJx

[Jeffrey Bacha @JeffreyBacha]

Read my new blog "Patients, the Center of our Efforts" via @SeekingAlpha https://t.co/fOG47qvOJx $DMPI

[Jeffrey Bacha @JeffreyBacha]

We are excited to be advancing VAL-083 into newly diagnosed GBM https://t.co/qt86vwzfQ8

[Jeffrey Bacha @JeffreyBacha]

VAL-083 represents a potential paradigm shift in the treatment of #GBM https://t.co/qt86vwzfQ8 $DMPI

[Jeffrey Bacha @JeffreyBacha]

Activation of STAR-3 trial & initiation of recruitment @ @DentInstitute is a momentous occasion for patients & $DMPI https://t.co/BwAJFvfjOe

[Jeffrey Bacha @JeffreyBacha]

We're excited for completion of 1st site initiation visit for STAR-3 pivotal Ph3 trial of VAL-083 in refractory #GBM https://t.co/BwAJFvfjOe